Form 4: Moderna CFO James Mock Reports Stock Option and Restricted Stock Unit Grants

Moderna's Chief Financial Officer, James M. Mock, reported the acquisition of stock options and restricted stock units in a recent SEC filing.

Summary

• James M. Mock, the Chief Financial Officer of Moderna, Inc., filed a Form 4 with the SEC on February 29, 2024.
• The filing reports transactions from February 27, 2024, including the acquisition of stock options and restricted stock units.
• Mock acquired 23,635 stock options with an exercise price of $96.20, vesting starting February 27, 2025.
• He also acquired 12,377 restricted stock units, vesting starting February 27, 2025.
• Additionally, Mock acquired 60,216 stock options with an exercise price of $96.20, vesting starting February 27, 2026.
• He further acquired 5,304 restricted stock units, vesting starting May 27, 2024.
• Mock also disposed of 3,632 common stock shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects standard executive compensation practices. The grants are positive for aligning management incentives, but the filing itself is a routine disclosure.

Positives

• The grant of stock options and restricted stock units to the CFO aligns his interests with those of the shareholders.
• The vesting schedules encourage long-term commitment from the CFO.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Stock option and RSU grants are a common form of executive compensation in the biotechnology industry, used to incentivize performance and align executive interests with shareholder value.
• Vesting schedules are typical, often spanning several years to encourage long-term commitment.
• The specific amounts and vesting terms would need to be compared to peer companies like BioNTech, Novavax, and CureVac to assess whether they are in line with industry standards.

Stakeholder Impact

• Shareholders may view the grants positively as they align the CFO's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates